Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center-Reference-Cited by-同舟云学术

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

Published:2012-07-25 Issue:19 Volume:586 Page:3410-3414
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Freund Yvonne R.,Akama Tsutomu,Alley M.R.K.,Antunes Joana,Dong Chen,Jarnagin Kurt,Kimura Richard,Nieman James A.,Maples Kirk R.,Plattner Jacob J.,Rock Fernando,Sharma Rashmi,Singh Rajeshwar,Sanders Virginia,Zhou Yasheen

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.febslet.2012.07.058/fullpdf

Reference14 articles.

1. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling;Conti;Annu. Rev. Biochem.,2007

2. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol. Rev.,2006

3. The preclinical pharmacology of Roflumilast – a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease;Hatzelmann;Pulmon. Pharm. Therap.,2010

4. Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumor necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis;McCann;Arthritis Res. Ther.,2010

5. Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis;Akama;Bioorg. Med. Chem. Lett.,2009

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pass the boron: benzoxaboroles as antiparasite drugs;Trends in Parasitology;2024-09

2. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19

3. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology;Chemical Reviews;2024-02-21

4. Synthesis of Boron-Containing Nucleoside Analogs;The Journal of Organic Chemistry;2024-01-16

5. ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study;European Journal of Pharmacology;2024-01